Coexpression of B7-1 and viral (“self”) transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes  by von Herrath, Matthias G. et al.
Immunity, Vol. 3, 727-738, December, 1995, Copyright 0 1995 by Cell Press 
Coexpression of B7-1 and Viral (“Self”) Transgenes 
in Pancreatic p Cells Can Break Peripheral Ignorance 
and Lead to Spontaneous Autoimmune Diabetes 
Matthias G. von Herrath,’ Sylvie Guerder,t* 
Hanna Lewicki,’ Richard A. Flavell,t 
and Michael B. A. Oldstone’ 
*Viral lmmunobiology Laboratory 
Department of Neuropharmacology 
Division of Virology 
The Scripps Research Institute 
10666 North Torrey Pines Road 
La Jolla, California 92037 
tSection of lmmunobiology 
Howard Hughes Medical Institute 
Yale University School of Medicine 
New Haven, Connecticut 06520 
Summary 
We evaluated the role of the costimulatory molecule 
87-l in overcoming perlpheral Ignorance in transgenic 
mice, which expressed the glycoprotein (GP) or nu- 
cleoproteln (NP) of lymphocytic choriomeningltls vi- 
rus (LCMV) as the self-antigen in pancreatic j3 cells. 
The viral transgenes or 87-l alone did not induce auto- 
immune diabetes (IDDM). However, in blgenic mice ex- 
pressing 87-l and LCMV-GP, anti-self (viral) cytotoxic 
T lymphocytes (CTL) were activated without viral in- 
fection and spontaneous IDDM occurred. In contrast, 
bigenic RIP-B7-1 x RIP-NP mice with thymlc expres- 
sion of the self (viral-NP) antlgen deleted the majority 
of their autoreactlve CTL and did not develop sponta- 
neous IDDM. However, these mice developed fast- 
onset IDDM 14 days after LCMV infection, whereassin- 
gle-transgenlc RIP-NP llttermates developed IDDM 
only within 4-5 months. Rapid IDDM was associated 
with Increased numbers of ant&elf CTL and a predom- 
inance of IFNy produced by islet-inflltratlng lympho- 
cytes, whereas single transgenic RIP-NP littermates 
with slow-onset IDDM displayed less anti-self CTL and 
more IL+ and IL-lO-producing T lymphocytes in pan- 
creatic infiltrates. 
Introduction 
Destruction of insulin-producing B cells of the islets of 
Langerhans leads to insulin-dependent diabetes mellitus 
(IDDM). However, the etiology of autoimmune type I IDDM 
is not clear (Baekkeskov and Hansen, 1990; Eisenbarth, 
1966). First, the self-antigen recognized by anti-self ef- 
fector cells is unknown. Second, the potential costimula- 
tory molecules that enhance the breaking of peripheral 
ignorance are unclear; and last, the effector cell(s), mole- 
cule(s), or both involved in p cell injury are controversial. 
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One hypothesis postulates a two-event sequence: first, 
contact with a virus early in life results in persistence of 
viral antigen in the isletsof Langerhans, causing theorgan- 
ism to be ignorant to this viral (self) gene that is located 
and expressed in the target cell. The second event is an 
infection with the same virus or an antigenically related 
pathogen later in life, which induces an immune response 
to the infecting virus that also cross-reacts with viral (self) 
antigens in the pancreatic fi cells, leading to their destruc- 
tion and IDDM. Likewise, it is possible that the first event is 
the expression of a self-protein that shares cross-reactive 
antigenic determinants or epitopes with a virus. This hy- 
pothesis is supported by development of the RIP-LCMV 
transgenic mouse model and its subsequent manipulation 
with viral infection (Oldstone et al., 1991; Ohashi et al., 
1991; von Herrath et al., 1994a). In these transgenic mice 
the viral gene (nucleoprotein [NP] or glycoprotein [GP] of 
lymphocytic choriomeningitis virus [LCMY) that is in- 
serted into the germline and expressed in pancreatic p 
cells is essentially a self antigen. However, peripheral ig- 
norance to the transgene can be broken, since upon infec- 
tion with LCMV in adulthood more than 95% of these 
transgenic mice generate an anti-viral (anti-self) CD6+ cy- 
totoxic T lymphocyte (CTL) response that leads to IDDM 
(Oldstone et al., 1991; Ohashi et al., 1991; von Herrath 
et al., 1994a). Our recent studies (von Herrath et al., 
1994a) have shown that RIP-LCMV (H-2b) mice express- 
ing the transgene only in their p cells do not delete any 
of their anti-self (viral transgene-specific) CTL and develop 
fast-onset IDDM within 14 days after LCMV infection. In 
contrast, RIP-LCMV mice that express the transgene in 
both their p cells and also in their thymus show a specific 
reduction of the generation of anti-self (viral transgene- 
specific) CTL activity (von Herrath et al., 1994a, 1994b). 
The reason for this reduction is that most anti-self (viral) 
CTL are deleted in the thymus in RIP-LCMV H-2b 
transgenic mice. In RIP-LCMV H-2d transgenic mice only 
high affinity CTL are deleted in the thymus and anti-self 
(viral) CTL with lower affinity are still found in the periphery 
(von Herrath et al., 1994b). While fast-onset IDDM in RIP- 
LCMV transgenic mice without thymic transgenic expres- 
sion is dependent only on CD6+ CTL, slow-onset IDDM in 
RIP-LCMV transgenic mice with thymic expression of the 
viral (self) antigen depends on both CD4’ and CD6+ T 
lymphocytes (von Herrath et al., 1994a). 
Activation of naive T lymphocytes is a multifaceted pro- 
cess probably requiring at least two signals. The first is the 
interaction of the T cell receptor (TCR) with the appropriate 
major histocompatibility complex (MHC)-peptide com- 
plex. The second is costimulation that can be provided by 
87-l and 87-2 (Jenkins, 1994; Sagerstrom et al., 1993; 
Chiodetti and Schwartz, 1992) or cytokines, or both (Sag- 
ertrom et al., 1993; Chiodetti and Schwartz, 1992). The 
87-l and 87-2 molecules are related to the immunoglobu- 
lin gene superfamily, and both molecules can be ex- 
pressed on the surface of professional antigen-presenting 
cells (APCs), such as activated B cells, macrophages, and 
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dendritic cells (June et al., 1994). Interaction of 67 with the 
CD28 ligand providesTcells with a costimulatory signal. In 
vitro studies have documented that signaling by the TCR 
alone is not sufficient to induce proliferation and interleu- 
kin-2 (IL-2) production by CD4+ T cells (Chiodetti and 
Schwartz, 1992; Allison, 1994; Harding et al., 1992). TCR- 
MHC interaction alone not only fails to activate T cells, 
but TCR stimulation in the absence of costimulation can 
lead to anergy or cell death (Allison, 1994; Harding et al., 
1992; Chen and Nabavi, 1994). Moreover, CTL activation 
is possible in the absence of most T-helper factors if co- 
stimulation by B7-CD28 interaction is provided (Harding 
and Allison, 1993, Gajewski et al., 1995). 
Several animal models have been used to analyze the 
role of 87 for T cell activation in vivo. Absence of B7- 
dependent responses has been documented in CD28- 
deficient mice (Green et al., 1994), and blocking of B7- 
CD28 interactions can induce tolerance (Boussiotis et al., 
1994). When costimulation is blocked by either anti-B7-1 
or anti-B7-2 antibodies, the incidence of autoimmune dis- 
eases can be differentially influenced (Kuchroo et al., 
1995; Lenschow et al., 1995) and opposite effects on the 
development of T cells into T-helper 1 (Thl) or Th2 pheno- 
types have been demonstrated (Freeman et al., 1995). 
However, the different functions of 87-l and 87-2 in T cell 
activation and their implication in autoimmunity are not 
yet fully understood (Harlan et al., 1995). 
We and others have generated transgenic mice that 
express 87-l locally in pancreatic 8 cells (Guerder et al., 
1994a; Harlan et al., 1994). In these RIP-B7-1 transgenic 
mice, expression of B7-1 alone does not lead to breaking of 
ignorance to potential islet-cell autoantigens unless other 
factors are provided. Accordingly, coexpression of MHC 
class II (I”) or tumor necrosis factor-a on islet cells together 
with 87-l provides sufficient additional signals to induce 
autoimmune diabetes in double-transgenic mouse models 
(Guerder et al., 1994a, 1994b). Further, Harlan and his 
colleagues (1994) showed that transgenic mice express- 
ing 87-l and LCMV-GP in pancreatic 8 cells develop 
spontaneous IDDM, but only if more than 90% of their 
circulating T cells were transgenic for a GP-specific TCR. 
Thus, B7-1 may transform nonprofessional APCs (Nicko- 
loff and Turka, 1994) such as 8 cells, into competent APCs, 
although other factors, such as high numbersof potentially 
autoreactive T cells (Harlan et al., 1994) inflammatory 
cytokines (Guerder et al., 1994a), or MHC up-regulation 
are important (Guerder et al., 1994b). 
To explore the potential role of 87-l in breaking immuno- 
logical ignorance to a viral transgene in the absence of 
additional inflammatory factors or high numbers of autore- 
active transgenic T cells, we generated double-transgenic 
mice that expressed the viral (self) transgene and 87-l 
locally in 8 cells. This allowed us to address several ques- 
tions. First, can 87-l expressed together with a viral (self) 
gene spontaneously activate an anti-self CTL response 
and initiate IDDM during the normal lifespan of the animal? 
Second, does the local expression of 87-l accelerate the 
development of IDDM after infection with a virus express- 
ing the same protein as the transgene? Third, if B7-1 en- 
hances autoimmunity, what is the mechanism? Results 
presented here show, in contrast with the report by Harlan 
et al. (1994) that the local expression of 87-l breaks the 
unresponsive state to the viral transgene as documented 
by the spontaneous generation of anti-self (viral) CD8+ 
CTL. Such doublstransgenic mice develop IDDM with in- 
filtrating CD4+ ,CD8+, and B lymphocytes accompanied 
by an up-regulation of MHC class I and II molecules in the 
islets of Langerhans. When the double-transgenic mice 
are infected with LCMV, 87-l transforms the slow-onset 
IDDM (occuring 3-8 months postinfection) into a fast- 
onset IDDM (2-4 weeks after viral infection). Production 
of Th2 cytokines is markedly reduced and replaced by a 
Thl cytokine profile in islets from double-transgenic mice 
with fast-onset IDDM as compared with islets of single- 
transgenic mice with slow-onset IDDM. Precursor fre- 
quency analysis of autoreactive CTL indicates an ampli- 
fication of low numbers of anti-self CTL through 
costimulation by 87-l and the increased numbers of auto- 
reactive (anti-viral) CTL are directly associated with an 
enhanced onset of IDDM. Thus, 87-1, when expressed 
in a local microenvironment, is associated with a shift in 
cytokine production from Th2 toTh1 and with an increased 
production of autoreactive lymphocytes that correlates 
with enhancement or acceleration of autoimmunity. 
Results 
RIP-GP and RIP-NP Single Transgenic Mice Have 
Peripheral CTL that Can Be Activated In Vitro to 
React with the GP or NP Transgene Product 
When splenic lymphocytes obtained from RIP-GP 34-20 
transgenic mice were incubated with Drosophila melano- 
gaster cells expressing the Db MHC class I molecule that 
were coated with LCMV-GPP peptide (amino acid resi- 
dues 278288), they became activated and were able to 
lyse specifically H-2b target cells infected with LCMV or 
coated with the GP2 peptide (Table 1). Such lymphocytes 
were unable to lyse H-2b targets coated with the Db- 
restricted LCMV-NP peptide (amino acid residues 398 
404) or H-2d targets infected with LCMV. These results 
were observed in multiple experiments, with two represen- 
tative experiments shown in Table 1. Similarly, splenic 
lymphocytes obtained from H-2b RIP-NP 25-3 mice could 
be activated to lyse syngeneic but not allogeneic target 
cells coated with the Db-restricted NP peptide (data not 
shown). In contrast with results obtained with lymphocytes 
from RIP-GP mice, activation of lymphocytes from RIP- 
NP mice was less frequent (three positive results in a total 
of seven experiments with RIP-NP mice compared with 
8 of 8 with RIP-GP mice). Likely this is the case, because 
there are larger numbers of potentially autoreactive lym- 
phocytes in the periphery of RIP-GP 34-20 mice than in 
RIP-NP 253 mice, due to expression of the transgene in 
the thymus in RIP-NP mice (von Herrath et al., 1994a), 
an observation that was confirmed by precursor frequency 
analysis displayed in Tables 2 and 3. Thus, peripheral 
ignorance exists in RIP-LCMV transgenic mice. These 
observations extend earlier results (Oldstone et al., 1991; 
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Table 1. Generation of Primary LCMV CTL from Splenic Lymphocytes of RIP GP34-20 Mice by In Vitro Priming 
Effector CTLs assayed 
Drosphilia Cells (09 incubated with 
Db GP2 
Peptids H-2b Spl Lymphocytes ET ratio 
Percent 5’Cr Released from 
lY Targets Coated with 
No GP2 GP2 peptide 
H-2d target 
LCMV 
Day 7 PO Spl CTL H-2b loo:1 
Day 7 P” Spl CTL H-2 1OO:l 
Db GP2 CTL clone 77-82 51 
Experiment Xl + Nontransgenics 
Experiment #2 
+ 
No 
+ 
+ 
No 
RIP GP34-20 
transgenics 
RIP GP34-20 
transgenics 
Nontransgenics 
RIP GP34-20 
transgenics 
RIP GP34-20 
transgenics 
1OO:l 
5O:l 
1OO:i 
50: 1 
1OO:l 
5O:l 
5O:l 
251 
591 
251 
5O:l 
25:l 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
4 
0 
0 
iii m 
5 
0 
0 
7 
ND 
5 
1 
2 
ND 
3 
ND 
4 
ND 
0 
ND 
CTL activity was determined as described in Experimental Procedures. Db target cells were RMAS cells coated with the LCMV-GPP peptide. 
Effector cells were either splenocytes harvested from nontransgenic mice 7 days after infection with 1 x 1Q pfu LCMV intraperitoneally, LCMV- 
GPP-specific CTL clone 77-82. or splenocytes recovered from nontransgenic or RIP-GP transgenic mice and stimulated for 6 days in vitro in the 
presence of Drosophila melanogaster cells expressing the Db molecule and coated with GP2 peptide. The in vitro stimulation is described in 
Experimental Procedures. Boxed areas record significant lysis of the target. ND, not determined. 
von Herrath et al., 1994a) showing that LCMV infection Coexpression of 87-l and Viral GP in Pancreatic fl 
generated an anti-self (GP or NP) CTL response, breaking Cells Induces an Anti-Self (Viral) CTL Response In Vivo 
this peripheral ignorance. Fly cells are probably able to that Leads to Spontaneous Autoimmune Diabetes 
activate naive unprimed CTL in vitro, because MHC-pep- Figure 1 (group A) shows the development of spontaneous 
tide density is extremely high on their surface. IDDM in the absence of LCMV infection in RIP-B7-1 x 
Table 2. Breaking of Peripheral Ignorance through Generation of Anti-Self (Viral) CTL in H-2b RIP-B7-1 x RIP-LCMV Transgenic Mice following 
Viral Infection: Injected with LCMV 
Transgene(s) 
expressed 
in 6 cells 
Thymic Days post 
Number of precursors 
expression LCMV 
Percent Yr release from target cells H-2b H-2d of anti-self CTL 
of LCMV-NP infection LCMV vvlGP w/NP NP- LCMV to GP to NP IDDM 
None No 7 40*9 40 f 6 20 f 6 40 f 10 6&2 1:270 1:420 No 
RIP-87-l No 7 3626 29 f 9 37 f 6 5026 0 1300 I:380 No 
RIP-GP No 7 50 f 9 20 f 3 26 f 1 35*6 0 I:400 I:500 No 
RIP-GP x 87-l No 7 52 f 7 20 f 4 22 f 3 36 f 12 2*2 1:350 1486 No 
RIP-NP Yes 7 42 f 6 24 f 4 6*4 8*3 IIt1 1:350 1:5,000 No 
RIP-NP x 87-l Yes 7 41 f 8 x3*9 9e6 10 f 6 3*2 1:250 1:3.000 No 
None No 26 50 f 10 39 f 5 40 f 6 55 * 12 522 1:2,500 1:2,900 No 
RIP-87-l No 28 75 f 6 20 f 2 44f4 54*2 0 1:1,906 1:2,300 No 
RIP-GP No 20 70 It 8 35 f 1 40*3 53*2 4fl 1:2.000 1:3.000 Yes 
RIP-GP x 87-l No 28 35 f 12 29 f 4 29i8 50 f 3 1*1 1:1,266 1:2,906 Yes 
RIP-NP Yes 28 62 f 6 54*9 8*3 13 f 7 5*3 1:2,300 1:20,006 No 
RIP-NP Yes 45 52 f 8 34*3 9*2 11 f4 4*2 1:3,500 1:15,009 No 
RIP-NP Yes 140 41 f 3 53 f 5 16 f 3 20 f 7 3*3 1:2,606 1:10,000 Yes 
RIP-NP x 87-l Yes 14 36*5 18 f 2 22zt6 22*5 0 1:2.560 1:5,340 Yes 
CTL activity was measured in RIP-LCMV x RIP-B7-1 mice at various times after challenge with 1 x l@ pfu of LCMV intraperitoneally. For 
assessment of primary CTL activities at day 7 post LCMV infection, single cell suspensions of spleen lymphocytes were used at effector to target 
(E:T) ratios of 561 and 25:l with data for 5O:l shown. For later timepoints postinfection (day 14 or later), CTL activity was determined from splenic 
lymphocytes harvested 14, 28, 45, or 140 days after viral challenge and placed in culture for 5 days (see Experimental Procedures). Transgenic 
mice selected for such analysis of secondary CTL either had normal blood glucose (180 f 20 mgldl) or elevated blood glucose (>300 mgldl). 
Secondary CTL cultures were used at E:T ratios of 5:i or 2.5:l with data for 5:l shown. Target cells used in all assays were BALBICII (H-8 and 
MC57 (H-2b) fibroblasts infected with LCMV or recombinant vaccinia viruses expressing NP or GP of LCMV or no LCMV proteins (wlscll) or 
uninfected target cells coated with LCMV-NP peptide (amino acids 396-404). All samples were run in triplicate and variance was <lo%. For 
precursor frequency analysis, H-20 MC57 fibroblasts (target cells) were infected with w/GP or w/NP as reported (von Herrath et al., 1994b). 
Variation of individual precursor frequencies between experiments was lo-30%. ND, not determined. 
Table 3. Breaking of Peripheral Ignorance through Generation of Anti-Self (Viral) CTL in H-2b RIP-67-1 x RIP-LCMV Transgenic Mice 
following Viral Infection: Injected with w/LCMV Recombinants 
Transgene(s) Thymic 
expressed expression 7$rMrt 
Number of precursors 
Percent 5Cr release from target cells H-2b H-2d of anti-self CTL 
IDDM day 28 
in 8 cells of LCMV-NP infection LCMV w/GP w/NP w/SC1 1 LCMV to GP to NP post-injection 
None or RIP-B7 No w/GP 19*3 231t4 9*2 IO f 3 2 f 3 1:5,000 1:50,000 No 
None or RIP-B7 No w/NP 18 f 5 11 * 2 28 f 10 11 f 4 4 f 3 1:50,000 I:6900 No 
RIP-GP No wlGP 2zt2 1322 12*2 10*3 0 1:7,390 1:50,000 No 
RIP-GP x 87-l No vvlGP 18*2 25*2 7*3 11 f 4 2 f 1 1:1,000 1:50,000 Yes 
RIP-GP x 07-l No vv/NP 20 f 3 9i4 25zt6 9zt8 0 1:50,000 1:5,580 No 
RIP-NP Yes VVINP 3*1 9&2 12+3 11*2 0 1:50,000 1:50,000 No 
RIP-NP x 87-l Yes vv/NP 19 f 4 11 f 3 22 f 4 9*2 0 1:5o,ooo I:5900 Yes 
RIP-NP x 87-l Yes VVIGP IO*4 27*5 8*3 9*4 4 f 2 1:4,900 1:50,000 No 
CTL activity was measured in RIP-B7-1 x RIP-LCMV mice at various times after challenge with 1 x IO7 pfu w/GP or w/NP intraperitoneally. 
CTL activity was assayed at 7 days (d7) following virus infection. Single cell suspensions of spleen lymphocytes were used at E:T ratios of 5O:i 
and 25:l with data for 50:1 shown. Precursor frequency and CTL activity analysis was performed as described for Table 2. 
Data shown were obtained in the same experiment. Data from one representative experiment are displayed. Results were confirmed in three 
other independent experiments. 
RIP-GP double-transgenic mice by 8 months of age. This 
occurs in 40% of such mice. In contrast, spontaneous 
IDDM did not arise over a 12 month observation period in 
single-transgenic littermates expressing either the LCMV 
proteins or the 67-l molecule alone, nor in double- 
transgenic mice expressing LCMV-NP and 67-l. 
All double-transgenic RIP-B7-1 x RIP-GP mice devel- 
oping spontaneous IDDM had inflammatory infiltrates in 
their islets of Langerhans, whereas neither single- 
transgenic nor double-transgenic mice that had not devel- 
oped IDDM had such infiltrates (Figure 1, panel A com- 
pared with panel 6). Infiltrates in the islets were composed 
of CD4+ and CD8+ T lymphocytes and B cells. Some F4/ 
80-positive macrophages were noted to be located to- 
wards the periphery of the islets (data not shown). Expres- 
sion of MHC class I and II molecules was enhanced in the 
area of the infiltrated islets. These histological findings 
resemble those of our previous report (von Herrath et al., 
1994a) with RIP-NP or RIP-GP transgenic mice after 
LCMV infection. 
Next, we tested whether pancreas or spleen of double- 
transgenic mice with IDDM contained LCMV-GP-specific 
CTL. As shown in Table 4, CTL specific for LCMV GP but 
not NP were found in spleens and pancreatic infiltrates of 
uninfected RIP-B7-1 x RIP-GP double-transgenic mice 
developing spontaneous IDDM. Littermates without such 
infiltrates orwithout IDDM did not have LCMV-specificCTL 
(data not shown). Precursor frequencies of anti-self (viral 
GP-specific) CTL in unprimed RIP-GP transgenic mice 
without IDDM were lower than 1:50,000 (Table 4). In con- 
trast, precursor numbers of anti-self CTL were at least 
8-fold higher (1:8,000) in RIP-B7-1 x RIP-GP transgenic 
mice with IDDM. IDDM, spontaneous CTL, or both were 
not detected in double-transgenic mice expressing 
LCMV-NP and 87-l and precursors of anti-self CTL were 
not found (frequency < 1:50,000; Table 4). Therefore, 
spontaneous IDDM was associated with the specific in 
vivo priming and increased frequencies of anti-self (vi- 
ral) CTL. 
Polymerase chain reaction (PCR) analysis showed ex- 
pression of LCMV-NP RNA in the pancreas and thymus 
of RIP-67-l x RIP-NP mice, whereas RIP-67-l x RIP- 
GP mice expressed the transgene only in the pancreas 
(data not shown). The lack of spontaneous IDDM in RIP- 
67-l x RIP-NP transgenic mice likely results from the 
partial elimination of anti-self (LCMV-NP specific) CTL in 
these mice via negative selection in the thymus, as re- 
ported for RIP-NP single-transgenic mice (von Herrath et 
al., 1994a). The outcome is that precursor frequencies of 
anti-self CTL (Table 2) are lower in RIP-NP mice. 
Virus-Induced Slow-Onset IDDM Is Accelerated by 
Pancreatic Expression of 87-l in RIP-NP Transgenic 
Mice and Develops Independently of CD4+ Cells 
We have previously shown that both RIP-NP and RIP-GP 
transgenic mice develop IDDM following LCMV infection 
(Oldstone et al., 1991; von Herrath et al., 1994a). In RIP- 
GP mice IDDM occurs rapidly with a 90% incidence at 1 
month following infection (Figure 1, group 6). Coexpres- 
sion of B7-1 and GP on islet cells only marginally acceler- 
ated the virus-induced IDDM. In contrast, the coexpres- 
sion of 67-l and NP in 8 cells transformed the usual 
slow-onset (8-6 months) into fast-onset IDDM (2 weeks). 
Hence, by 2 weeks after LCMV infection, 100% of RIP- 
87-l x RIP-NPdouble-transgenic mice developed IDDM, 
whereas none of the infected single-transgenic RIP-NP 
littermates had developed IDDM at this time. Indeed, it 
took 6 months for 80% of RIP-NP single-transgenic mice 
to develop IDDM after LCMV infection (Figure 1, group 
B). As seen in Figure 1, 3 weeks after LCMV infection, 
larger infiltrates and greater destruction of islet cells were 
found in double-transgenic RIP-67-l x NP mice (panel 
D) than in single-transgenic RIP-NP littermates (panel C). 
We then examined whether the fast-onset IDDM was 
associated with breaking of peripheral ignorance and with 
appearance of NP-specific CTL in RIP-67-I x RIP-NP 
double-transgenic mice. Table 2 shows that 7 days after 
LCMV infection, RIP-NP double- and single-transgenic 
mice had no detectable primary anti-self CTL reactivity 
(<lo%) to the LCMV-NP and had low precursor frequen- 
cies of anti-self (LCMV-NP) CTL. However, NP-specific 
CTL were detected at 14 days post LCMV infection in the 
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87.1 Expressed In the Islets of Langsrhans can Induce 
Soontaneous IDDM In RIP-GP Mke 
Group B: 
B7.1 Expressed In the Islets of Langerhans can Accelerate 
Virus-Induced IDDM In RIP-NP Transgenk Mice 
Vlrsl chshlge (LCW) NPI- NPtB7.1 
Vacclnla Virus Recomblnants Expressing LCMV Proteins Induce IDDM in RIP-LCMV 
Transgenk Mice Only when Costlmulatlon by 87.1 Is Provided 
GmuoC: - vhl chalhn~ (Wl(iP or WNP) QPI. QPm7.1 
Figure I. Incidence of Spontaneous IDDM or Virus-Induced IDDM in RIP-B7-1 x RIP LCMV Transgenic Mice 
(Group A) Occurrence or lack of spontaneous IDDM (blood glucose > 300 mg/dl, lymphocytic infiltration, and destruction of the 5 cells of the islets 
of Langerhans) in single-transgenic RIP-B7-I, RIP-NP, and RIP-GP mice or in double-transgenic RIP-87-l x RIP-GP or -NP mice in the absence 
of LCMV infection is shown. Blood glucose levels were measured at 2 week intervals and 15 mice were analyzed per group. Spontaneous IDDM 
occurred in 40% of RIP-B7-1 x RIP-GP transgenic mice but not in the other transgenic lines. (A, left) shows a pancreatic islet from a &month-old 
RIP-GP transgenic mouse, while (B, right) shows an islet from a &month-old RIP-B7-1 x GP mouse. Neither mouse received an injection of 
LCMV. 
(Group B) Occurrence of IDDM in single-transgenic RIP-NP and RIP-GP mice or in doubletransgenic RIP-87-l x RIP-GP or -NP mice after 
infection with 1 x 105 pfu LCMV intraperitoneally. Mice were infected at 6-3 weeks of age and were divided into groups with normal CD4 cell 
counts or groups, where CD4 cells were depleted by antibodies (see Experimental Procedures). CD4+ depletion did not influence the development 
of IDDM in mice with fast-onset diabetes, but abrogated the development of IDDM in singletransgenic RIP-NP mice. Each group was comprised 
of 8-10 mice; blood glucose was measured every 2 weeks. (C. left) shows a representative islet of Langerhans from a RIP-NP mouw 3 weeks 
after challenge with LCMV. A modest degree of infiltration is apparent, blood glucose levels were not elevated. (D, right) shows a representative 
islet from a double-transgenic RIP-87-l x NP mouse 3 weeks after challenge with LCMV. A marked lymphocytic infiltration is observed and was 
accompanied by a blood sugar of > 500 mgldl. 
(Group C) Incidence of IDDM in single-transgenic RIP-NP and RIP-GP mice or in double-transgenic RIP-B7-1 x RIP-GP or -NP mice after 
infection with vaccinia virus recombinants expressing LCMV-NP or -GP. Blood glucose levels were measured at 2 week intervals and each group 
contained 8-10 mice. Vaccinia virus/LCMV recombinants (w/NP or w/GP) were injected at a dose of 1 x IO’ pfu intraperitoneally into & to 
&week-old mice. Experimental groups that had an identical time course for the incidence of IDDM are represented together. (E, left) shows an 
example of a pen-islet infiltration found in a RIP-GP mouw 4 months after w/GP injection. Only very few cells are found in the islet and blood 
glucose was 155 mg/dl. (F, right) shows the contrasting picture observed in RIP-B7-1 x GP transgenic mice 1 month after infection with w/GP. 
Islets were destroyed, marked infiltration occurred, and blood glucose was > 500 mg/dl. Similar results as those shown in (E) and (F) occurred 
with RIP-B7-1 x RIP-NP transgenic mice 1 month after infection with w/NP. 
spleen and pancreas of RIP-87-l x RIP-NP double- 28 postinfection, although some anti-self (viral NP) CTL 
transgenic mice after in vitro stimulation. At this time IDDM were found at later stages in prediabetic (day 45) or dia- 
was apparent. The frequencies of anti-self CTL were 4-fold betic mice (day 140). Data from control mice that did not 
higher in RIP-B7-1 x -NP double-transgenic mice (1: express NP (Table 2) confirmed that a significant reduction 
5,340; Table 2) compared with single-transgenic RIP-NP in generation of anti-self (LCMV-NP-specific) CTL was de- 
mice (1:20,000; Table 2). Single-transgenic RIP-NP lit- tected only in transgenic mice expressing the transgene 
termates did not have detectable NP-specific CTL activi- in the thymus as well as in the islets. NP-specific CTL 
ties in the pancreas or spleen on day 14 or even by day frequencies at day 7 post LCMV infection were 1:420 in 
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Table 4. Breaking of Peripheral Ignorance by Spontaneous Generation of Anti-Self (Viral) CTL in Nonvirus-Treated H-2 RIP-B7-1 x 
RIP-LCMV Transgenic Mice 
Transgene(s) Thymic 
expressed expression 
in p cells of LCMV-NP 
Percent “Cr release from target cells H-2b 
LCMV vv/GP vv/NP GP-2,pt.e 
H-T 
LCMV 
Numberof precursors of 
anti-self CTL 
to GP to NP IDDM 
None No 0 0 0 0 0 <1:50,000 No 
RIP-87-l No 0 0 0 0 0 <1:50,000 No 
RIP-GP No 0 0 0 0 0 <1:50,000 No 
RIP-GP x 87-l No 62 * 15 34 f 14 2fl 25*7 0 1:6,000 1:5o,ooo Yes 
p: 28 f 9 15 f 5 5+3 3*2 0 ND Yes 
RIP-NP Yes 0 0 0 0 0 <1:50,000 No 
RIP-NP x 87-l Yes 0 0 0 0 0 <1:50.000 No 
CTL activity was measured in normal nonviral-injected single trangenic RIP-LCMV and RIP-BF1 mice, as well as doubly transgenic RIP-B7-1 
x RIP-LCMV mice. Splenocytes were harvested from 8 to lBmonth-old transgenic mice not infected with LCMV. After cultivation for 4-8 weeks 
on feeder macrophages, splenic lymphocytes were harvested and CTL activity was determined in a 5 hour s’Cr release assay. The effector to 
target ratios used were 2O:l and 1O:l with data for 1O:l shown. Target cells used were BALS/C17 (H-27 and MC57 (H-29 fibroblasts infected with 
LCMV or vaccinia viruses expressing NP (w/NP) or GP (vv/GP) of LCMV or uninfected cells coated with LCMV-GP2 peptide (amino acids 276 
286). In a number of experiments, lymphocytes were harvested directly from the pancreas (p:). All samples were run in triplicate and variance 
was <lo%. For precursors frequency analysis, H-2b MC57 fibroblasts (target cells) were infected with w/GP or w/NP. Precursor numbers from 
the different groups of transgenic mice shown were obtained in the same experiment. Data from one of three representative experiments are 
displayed. Similar findings were noted in three independent experiments. Variation of individual precursor frequenceis between experiments was 
lO-30%. ND, not determined. 
non-transgenic mice as compared with 1:5,000 in RIP- 
NP transgenic mice. 
Pancreatic expression of 87-l circumvented the need 
for CD4+ help in the virus-induced IDDM of RIP-NP 
transgenic mice. Virus-induced slow-onset IDDM in RIP- 
NP H-2bsingle-transgenic mice dependson both CD4+ and 
CD8+ lymphocytes (von Herrath et al., 1994a). In contrast, 
fast-onset IDDM of RIP-B7-1 x RIP-NP double-transgenic 
mice that follows LCMV infection requires only the partici- 
pation of CD8’ lymphocytes, as depletion of CD4+ cells 
in vivo (Figure 1, group B) did not circumvent the IDDM. 
CD4+ lymphocytes recovered from transgenic mice with 
both slow- and fast-onset IDDM proliferated equally well 
when incubated with LCMV antigen. Specific 3H incorpora- 
tion by CD4+ T lymphocytes recovered from transgenic 
mice 40 days after LCMV infection and cultivated with 
LCMV antigen was 3500 & 300 cpm for RIP-B7-1 x RIP- 
NP mice, 3500 +: 500 cpm for RIP-NP mice, 4500 f 700 
cpm for RIP-B7-1 mice, and 320 f 60 cpm for transgenic 
mice not infected with LCMV. 
Expression of 67-l In Situ in Islets Enhances 
Susceptlbllity to IDDM in RIP-LCMV Transgenlc 
Mice when Only Low Numbers of Anti-Self CTL 
Are Induced 
Our previous experiments (J. Dockter and M. B. A. O., 
unpublished data) and those of others (Ohashi et al., 1991; 
Harlan et al., 1994) showed that infection of RIP-LCMV 
transgenic mice with vaccinia virus recombinants express- 
ing NP or GP of LCMV (w/GP or w/NP) failed to induce 
IDDM and rarely caused islet infiltration, unless an addi- 
tional inflammatory stimulus such as tumor necrosis fac- 
tor-a was provided in the islets (Ohashi et al., 1993). There- 
fore, we performed experiments to examine whether 
expression of 87-l in the islets enhanced the susceptibilty 
to IDDM after infection with vaccinia virus recombinants. 
All double-transgenic RIP-B7-1 x RIP-LCMV mice mani- 
fested IDDM 4 weeks after infection with vaccinia virus 
recombinants expressing NP or GP (Figure 1, group C), 
whereas similarly infected single-transgenic (RIP-NP or 
RIP-GP) littermates did not develop IDDM over a 12- 
month observation period. The immune response causing 
IDDM was specific, since inoculation of w/GP failed to 
induce IDDM in RIP-B7-1 x RIP-NP transgenic mice and 
infection with w/NP did not induce IDDM in RIP-B7-1 x 
RIP-GP transgenic mice. Although infiltration into the is- 
lets was never found 3 months after infection with w/GP 
in single-transgenic RIP-GP mice, peri-insulitis was occa- 
sionally observed (Figure 1, group C). In contrast, the de- 
gree of infiltration was much larger in RIP-87-l x RIP- 
LCMV double-transgenic mice infected with the same w 
recombinants (Figure 1, group C). Low levels of anti-self 
(GP- or NP-specific) CTL activity was found 7 days after 
infection with w recombinants in RIP-B7-1 x RIP-LCMV 
mice, but did not occur in the single-transgenic mice(Table 
3). Precursor frequencies of anti-self CTL after infection 
with w/LCMV recombinants were up to 1 O-fold increased 
in these double-transgenic mice when compared with pre- 
cursor frequency levels detected in single-transgenic RIP- 
LCMV mice (Table 3). 
Focal Coexpresslon of 67-l in fl Cells Enhances 
the Kinetics of Development of a Predominantly 
Thl-Type Cytoklne Profile from the Ordinarily Found 
Mixed Thl/ThP Profile Secreted by Lymphocytes 
Infiltrating Islets of RIP-LCMV transgenic Mice 
Differences in Thl and Th2 responses have been impli- 
cated in regulating autoimmunity. To test whether Thl- or 
Th2- type responses predominated in islets of transgenic 
mice with fast-onset IDDM (87-l expressed in islets) com- 
pared with those with slow-onset (no 67-l expressed in 
islets), production of Thl cytokines, IL-2 and interferon? 
(IFNr), or Th2 cytokines, IL-4 and IL-10 by infiltrating lym- 
phocytes was assessed. Cytokines were detected immu- 
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Figure 2. Cytokine-Producing Cells Found in the Pancreas of RIP-67-l x RIP-NP and RIP-NP Transgenic Mice 
lmmunohistochemical staining of 6 uM sections of islets was performed on at least three different sections per mouse; the particular strain and 
cytokine under observation is indicated in the titles. Representative sections shown were similar for each mouse. Comparable obsewations were 
made in at least 7 transgenic mice in two different experimental groups. All sections on display were processed and stained at the same time. 
nohistochemically in spleens (data not shown) and infil- 
trates of RIP-NP and RIP-67-l x NP transgenic mice 
after LCMV infection (Figure 2), but not in normal islets. 
Production predominantly of IL-4 occurred in single- 
transgenic RIP-NP mice that had not developed IDDM. 
In contrast, IFNy secretion predominated in areas where 
islets had been infiltrated by CD4+ and CD8+ cells of 
transgenic mice with 87-l expression who developed 
IDDM (Figure 2). 
The ELISPOT test was then used to quantitate the num- 
bers of lytTfphOCyt66 producing the individual cytokines. 
Both Thl cytokines (IL-2, IFNy) and Th2 cytokines (IL-4, 
IL-lo) were produced by activated lymphocytes passing 
through the pancreas of nontransgenic (data not shown) 
or RIP-B7-1 transgenic mice after infection with LCMV 
(Figure 3). Maximal responses were observed on day 7 
after infection and declined over time. Similar results were 
observed with RIP-NP single-transgenic mice before the 
onset of IDDM. By contrast, RIP-GP mice that develop 
fast-onset IDDM after LCMV infection demonstrated an 
almost complete loss of IL-4- and IL-lo-producing cells. 
Similarly, the disappearance of Th2 type cells was ob- 
sewed in RIP-B7-1 x GP and RIP-B7-1 x NP transgenic 
mice after LCMV infection. For example, numbers of lym- 
phocytes secreting IL-4 and IL-10 were approximately 
5fold lower in RIP-B7-1 x NP double-transgenic mice 
with IDDM at 14 days postinfection than in RIP-NP mice 
without IDDM at day 45 postinfection. Moreover, Thl- and 
not ThPsecreting lymphocytes were found in uninfected 
diabetic RIP-B7-1 x GP transgenic mice that spontane- 
ously developed diabetes. Interestingly, production of Thl 
cytokines appears similar in all cases regardless of the 
development of IDDM. Thus, while LCMV induces both 
Thl and Th2 cytokine production, a marked reduction of 
The-type cytokines (IL-4, IL-lo) was found in the pancreas 
of transgenic mice with IDDM occurring as early as 7 days 
after LCMV infection in RIP-B7-1 x RIP-LCMV double- 
transgenic mice or RIP-GP single-transgenic mice. 
Discussion 
A central step leading to autoimmune diabetes and other 
autoimmune diseases is the breaking of peripheral igno- 
rance to self-antigens (Miller and Flavell, 1994). The RIP- 
LCMV transgenic mouse model (Oldstone et al., 1991; 
Ohashi et al., 1991), which places a known self-antigen 
(viral protein) in 8 cells, offers an opportunity to explore 
the pathogenesis of IDDM. Recent studies have shed light 
on the role of several cytokines (von Herrath et al., 1995; 
Lee et al., 1994, 1995; Stewart et al., 1993) a6 well a6 the 
thymus (von Herrath et al., 1994a) in the pathogenesis 
of IDDM. Here, we analyze the role of the costimulatory 
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Figure 3. Number of Lymphocytes Producing 
11-2, IL-Q, IL-lo, and IFNy Recovered from 
the Pancreas of RIP-B7-1 x RIP-LCMV 
Transgenic Mice 
ELISPOT assays were carried out as described 
in Experimental Procedures. Number of posi- 
tive cells for each cytokine is shown in black 
bars f 1 SEM. The origin of lymphocytes is 
indicated on the left side of each panel and 
preparation is described in Experimental Pro- 
cedures. Pancreas from uninfected single- 
transgenic mice did not contain enough lym- 
phocytes to allow analysis. Pancreata from 
single transgenic RIP-B7-1 mice without infil- 
tration contained few lymphocytes after LCMV 
infection and cells obtained from 3-4 different 
molecule 67-l in the breaking of peripheral ignorance. We 
note several interesting and novel findings. First, costimu- 
lation by B7-1 provided through in situ expression on islet 
cells breaks immunologic ignorance to a self (viral) antigen 
in vivo in otherwise normal unmanipulated transgenic 
mice. Second, the 87-l molecule can transform virus- 
induced slow-onset IDDM that occurs when only low num- 
bers of anti-self (viral) CTL are present, into a fast-onset 
IDDM. Third, enhancement of autoimmunity in the pres- 
ence of 87-l is associated with the amplification of autore- 
active CTL and with shifting the local pancreatic cytokine 
profile from Th2 to Thl. 
The data presented here leads us to hypothesize the 
following scenarios for the induction of autoimmune diabe- 
tes. In uninfected transgenic mice potentially autoreactive 
T cells specific for peripheral self-antigens are present 
(Table 1) and likely circulate through the organism. In the 
absence of a viral challenge, these cells remain silent, 
are not activated, and therefore do not cause disease. 
However, when otherwise nonprofessional APCs provide 
costimulation by 87-l in the islets along with expression 
of self (viral) antigen, these T cells, when circulating 
through the pancreas, can become activated and cause 
IDDM. Despite using inbred strains of mice that express 
equivalent levels of the LCMV and 87-l transgenic on their 
f3 cells, only40% of such mice developed IDDM. A possible 
explanation is that nonactivated anti-self T cells infre- 
quently enter the islets, unless additional inflammatory 
factors are provided (Lee et al., 1995). 
IDDM rarely occurred in RIP-B7-1 single-transgenic 
mice and less than 2% of such mice developed disease 
(Guerder et al., 1994a). This indicates that 87-l alone can 
not usually break ignorance to self-antigens normally ex- 
pressed by islet cells. Nevertheless, spontaneous IDDM in 
RIP-B7-1 x RIP-GP transgenic mice occurred, probably 
because the viral GP was expressed more abundantly on 
5 cells than other natural self-antigens usually present on 
islet cells. The likely outcome is generation of increased 
numbers of self-reactive (viral GP-specific) CTL. 
Our finding of spontaneous IDDM in RIP-B7-1 x RIP- 
GP transgenic mice stands in contrast with the report of 
Harlan et al. (1994) in which spontaneous activation of 
potentially anti-self CTL and development of diabetes did 
pancreata were pooled. 
not occur unless an abundance of TCR transgenic T cells 
(>90%) was provided (TCR x RIP-GP x RIP-B7-1 triple- 
transgenic mice). One possible explanation is that 87-l 
expression in RIP-B-/-l transgenic mice used in the Har- 
lan report (1994) was lower than in our RIP-B7-1 
transgenic mice. Expression levels of 87-l as assessed 
by immunohistochemical analysis were higher in our 
transgenic mice than levels of 87-l normally found on 
APCs. In agreement with our findings, the RIP-B7-1 x 
GP model of Harlan et al. (1994) supports the concept 
that development of spontaneous autoimmune disease is 
dependent on the number of potentially autoreactive T 
cells present. 
Previous studies with the RIP-LCMV transgenic model 
showed that coexpression of IFNy in islets together with 
LCMV proteins led both to enhanced spontaneous autoim- 
mune diabetes and to the generation of anti-self (viral 
transgenic-specific) CTL (Lee et al., 1995). By contrast, 
expression of IL-2 and IL-1 0 together with LCMV transgenes 
in the pancreas did not lead to spontaneous CTL activation 
or IDDM (von Herrath et al., 1995; Lee et al., 1994). These 
findings show that in addition to 87-1, IFNy can break 
peripheral ignorance. How this occurs is not clear and 
whether the mechanism of breaking of peripheral igno- 
rance by 87-l or IFNy are similar or different is not yet 
known. 
Constitutive expression of 87-l on islet cells changed 
the kinetics of the virus-induced slow-onset IDDM to fast- 
onset IDDM in RIP-NP H-2b transgenic mice. Slow-onset 
IDDM occurred in RIP-NP mice, because most but not all 
anti-self (NP-specific) CTL had been eliminated by nega- 
tive selection in the thymus (von Herrath et al., 1994a). 
Owing to the small numbers of activated anti-self CTL, it 
is likely that the event of an autoreactive CTL entering the 
pancreas was less frequent in the slow-onset IDDM model 
than in the fast-onset IDDM observed in RIP-GP mice, 
which do not delete their anti-self CTL by negative selec- 
tion. Precursor frequency analysis (Table 2) showed that 
only small numbers of anti-self CTL are available to enter 
the pancreas in RIP-NP mice. The development of IDDM 
in these mice depends on additional factors provided by 
CD4+ helper cells (Ohashi et al., 1993, von Herrath et al. 
1994a). Local pancreatic expression of IL-2 potentiated 
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IDDM in these RIP-NP transgenic mice after LCMV prim- 
ing, but did not eliminate the need for CD4+ help. This 
suggested that other CD4+-dependent factors might be 
required (von Herrath et al., 1995). However, when costim- 
ulation by 87-l was provided in situ in RIP-NP transgenic 
mice, the need for CD4+ help was eliminated (Figure l), 
and IDDM developed rapidly after LCMV infection. 
Infection with vaccinia virus recombinants expressing 
NPor GPof LCMVcaused IDDMonlyin double-transgenic 
RIP-BI-1 x RIP-LCMV mice, but not in single-transgenic 
RIP-LCMV littermates (Figure 1; Tables 2 and 3). These 
vaccinia virus recombinants induced LCMV-specific CTL, 
but in nontransgenic and RIP-LCMV transgenic mice their 
frequencies were low so that no primary (day 7) CTL re- 
sponse but only a secondary memory CTL response was 
detected (Tables 2and 3; Whitton, 1990). In contrast, RIP- 
87-l x RIP-LCMV transgenic mice made a primary 
LCMV-specific CTL response after infection with vaccinia 
virus recombinants expressing NP or GP and developed 
IDDM, likely owing to the local amplification of low num- 
bers of anti-self CTL that entered the pancreas. 
Taken in toto, our observations strongly suggest a direct 
correlation between the development and frequency of 
autoimmune diabetes with the number of precursors of 
autoreactive CTL. We propose that a local expansion 
of anti-self CTL occurred after entering the pancreas and 
coming into contact with 9 cells that expressed both viral 
(self) antigen and 87-l. As a result, large numbers of anti- 
self CTL were generated locally and led to fast-onset 
IDDM. Recent experiments indicated that expression of 
87-l not only leads to clonal expansion of CTL but also 
induced the maturation of precursor CTL into functional 
effector CTL (S. G. and R. A. F., unpublished data). In 
addition, it is likely that B7-1 induced a change in the local 
cytokine milieu from Th2 to Thl and this increased the 
production of anti-self CTL. 
A direct link between cytokine milieu and the develop- 
ment of autoimmune diabetes was observed (Figures 2, 
3). Islets of transgenic mice with fast-onset IDDM and pan- 
creatic expression of 87-l contained less The-type cyto- 
kine (IL-4, IL-lO)-producing cells than islets from 
transgenic mice with slow-onset IDDM or nontransgenic 
spleens at the same time after infection (Figure 3). This 
supports the concept that constitutive expression of 87-l 
can influence the local microenvironment leading to the 
reduction in numbers of ThP-type T lymphocytes. Recent 
results from L. Glimcher and her colleagues (Kuchroo et 
al., 1995) have indicated that blocking 87-l interactions 
withantibodiesdecreasesseverityof autoimmunedisease 
(EAE), whereas blocking 87-2 interactions increases dis- 
ease severity. As supported by other studies (Paul and 
Seder, 1994; Modlin and Nutman, 1993; Scottetal., 1994), 
these data add to the evidence that predominance of either 
Thl- or ThPtype cytokines in inflammation may play a role 
in the regulation of autoimmune disease. Similarly, we 
found in all cases of spontaneous or virus-induced IDDM 
that a specific disappearance of ThP-type cytokines re- 
sulting in a predominance of Th 1 cytokines was associated 
with the development of IDDM. Thus, therapeutic interven- 
tions that successfully maintain a Th2 cytokine profile 
while inhibiting or replacing a Thl profile of infiltrating lym- 
phocytes may be helpful in treating IDDM. Studies to test 
this hypothesis are currently underway. 
Exparimrntal Procedures 
Transgenic Mouse Lines 
The transgenic mouse lines expressing the LCMV-NP (RIP-NP 25-3) 
and GP (RIP-GP 34-20) were generated in H-2b (C57BU6J) mice using 
the RIP vector and cDNA clones for LCMV-NP and -GP (Oldstone 
et al., 1991). RIP-GP 34-20 mice expressed the transgene only in their 
6 cells, while RIP-NP 25-3 mice expressed the transgene in both their 
pancreatic 8 cells and their thymi, but not in other tissues (von Herrath 
et al., 1994a). Neither group of transgenic mouse lines displayed any 
spontaneous mononuclear cellular infiltrate in or around the islets nor 
did they develop IDDM (blood glucose levels above 300 mg/dl, pancre- 
atic insulin levels below 20 pg insulin per gram of pancreatic tissue) 
unless challenged with LCMV (Oldstone et al., 1991). Transgenic mice 
expressing the human 87-l molecule were generated as reported 
(Guerder et al., 1994a). These mice were transgenic for the human 
87-l cDNA driven by the RIP and expressed the 87-l molecule only 
in the 8 cells of the pancreas (Guerder et al., 1994a). The RIP-67-l 
transgenic mice had no mononuclear cell infiltrates in or around their 
islets and fewer than 2% manifested spontaneous IDDM. Doubly 
transgenic mice that expressed both LCMV-NP or -GP and 87-l lo- 
cally in their 6 cells were made by mating H-2b RIP-LCMV to RIP- 
67-l mice. Progeny were bred for two generations to the C57BU6.f 
(H-Z?!) background, and expression of LCMV-NP or -GP and 87-l 
transgenes was confirmed by slot-blot analysis (Oldstone et al., 1991; 
Guerder et al., 1994a; Maniatis et al., 1990). For RNA analysis, RNA 
was extracted from peripheral blood mononuclear cells and organs 
(thymus and pancreas) using the GTC method (von Herrath et al., 
1994a; Maniatis et al., 1990). Expression of LCMV RNA was analyzed 
by RT-PCR (von Herrath et al. 1994a) run for 40 cycles, after which 
the products were analyzed on a 3% agarose gel. 
Virus 
The virus used was the Armstrong (ARM) strain of LCMV, clone 53b. 
Its origin, quantitation by plaquing, sequence, and biological proper- 
ties have been described (Dutko and Oldstone, 1983). Vaccinia virus 
recombinants expressing GP or NP of LCMV were generated and 
titered as described (Whitton, 1990; Whitton et al., 1986). 
CTL Assays and In Vltro Culture of ML Lines 
CTL activity was determined in a 5 hr in vitro YZr release assay (Old- 
stone et al., 1991). Samples were run in triplicate and variance was 
<lo%. To judge CTL activity, uninfected targets or those infected with 
either LCMV-ARM (MO1 1) or vaccinia virus-expressing LCMV-NP or 
LCMV-GP (MO1 3) were used. Target cells were H-2b (MC57) and H-2’ 
(BALBlcl7)fibroblasts. Lymphocytes from spleensof E-to 12-week-old 
unimmunized mice or mice inoculated intraperitoneally 7 days earlier 
with 1 x lo5 pfu of LCMV (ARM) or 2 x lo7 pfu of vaccinia virus 
recombinants expressing GP or NP of LCMV (w/GP or w/NP) were 
used as effecters at 50:1, 25:1, and 12:l effector:target (ET) ratios, 
respectively. H-2b-and H-2Qestricted LCMV-specific CTLclones(Lew- 
icki et al., 1992) were used at E:T ratios of lO:l, 51, and l:l, respec- 
tively. Secondary CTL lines were generated and maintained as de- 
scribed (von Herrath et al., 1994a, 1995; Lee et al., 1995) and used 
at E:T ratios of 1O:l and 5:l. Uninfected target cells were coated with 
peptides at 30 ug/well 30 min prior to adding CTL and starting the 5 
hr incubation for the 5’Cr release assay. To determine CTL activity 
after secondary stimulation, spleen cells harvested from mice 30-120 
days after primary inoculation with 1 x 105 pfu LCMV intraperitoneally 
were incubated with MHC-matched irradiated LCMV-infected macro- 
phages in the presence of T cell growth factor and irradiated syngeneic 
spleen feeder cells for 5-10 days. 
Precursor Frequency Analysis 
For precursor frequency analysis (limiting dilution analysis), spleen 
cells were harvested on day 7,28,60, SO, and 120 after primary LCMV 
infection. These cells were diluted serially and cultivated in 96-well 
flat-bottomed plates in the presence of T cell growth factor and synge- 
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neic irradiated LCMV-infected (lo3 pfu/ml) spleen cells (106/well). After 
5-9 days, each well was assayed for cytotoxic activity (described 
above) on target cells that were uninfected, or infected with LCMV 
or vaccinia viruses and expressed GP or NP. Positive cultures were 
defined as specific lysis 3 SD above the lysis found in negative controls 
(3% f 2% for all experiments shown). The fraction of negative cul- 
tures was determined for each dilution (46 cultures total per dilution). 
Precursor CTL (pCTL) numbers were assessed as follows: The fraction 
of negative cultures (y axis) was plotted on a semilogarithmic scale 
against the number of splenocytes per culture (x axis). pCTL frequen- 
cies are defined by the slope of the linear regression between at least 
three separate data points. The formula used was f I (lna-lnyj/n; f 
is the frequency of pCTL; n, the number of splenocytes added to each 
culture; a, the y axis intercept (in our experiments 100% * 4%); and 
y, the percentage of negative cultures. 
Detection of Peripheral Ignorance/In Vitro Induction of CTL 
Functional cDNA for the H-2Db molecule was obtained using a retrovi- 
ral shuttle vector (Joly and Oldstone. 1991). Drosophila melanogaster 
cells express large amounts of empty MHC molecules (Jackson et al., 
1992; Matsumura et al., 1992) after transfection with the H-2Db cDNA. 
Cells were grown in Insect Xpress Medium (Whittaker Bioproducts, 
Walkersville, Maryland) at 26OC. Expression of Db molecules was in- 
duced using CuSO, at a final concentration of 0.7 mM and Db expres- 
sion was confirmed after 24 hr by FACS analysis using a monoclonal 
antibody to MHC class I Db (Joly and Oldstone, 1991). When more 
than 70% of the transfected Drosophila cells expressed Db molecules 
after CuSO, induction, they were harvested 24 hr later and 1 x 10’ 
fly cells were incubated for 2-3 hr at 26OC in 50 ml of Insect Xpress 
medium containing LCMV peptides (FQPQNGQFI, LCMV-NP and 
SGVENPGGYCL, LCMV-GPP) at a final concentration of 200 PM. 
Following a 1 hr incubation at 37OC, fly cells were washed by centrifu- 
gation and resuspended in RPM containing 10% fetal calf serum 
(FCS). For in vitro CTL induction, fly cells were incubated with H-2” 
splenocytes at 150, 1:20, and 1 :l 0 ratios, respectively, for 6 days at 
37OC in a humidified 5% CO, incubator. CTL assays were performed 
as described above but using SICr-labeled RMAS (H-29 cells as target 
cells that were grown for 36 hr at 26“C in RPM1 containing 7% FCS. 
LCMV-peptides were preincubated at a final concentration of 10 PM 
with the target cells for 1 hr prior to the CTL assay, and excess amounts 
of peptides were removed by washing cells three times. Effector splen- 
ocytes were harvested from the incubation with theflycells bycentrifu- 
gation and used at E:T ratios of lOO:l, 50:1, and 25:1, respectively, 
in the CTL assay. 
Prollferatlon Assays 
Spleen cellswere harvested 9 or 40 days after LCMV infection of mice. 
lnguinal lymph nodes were obtained 9 days after animals were primed 
with purified ultraviolet (UVHnactivated LCMV inoculated at the base 
of the tail (von Herrath et al., 1994a). Splenocytes were added to nylon 
wool columns both to enrich for lymphocytes and to delete APCs (Ka- 
saian and Biron, 1990; Kasaian et al., 1991). APCs consisted of 2 x 
10Sirradiatedsyngeneicspleen cells perwell. When indicated, purified 
UV-inactivated LCMV was added at 0.6 ug/ml final concentration. Anti- 
CD4 and -CD6 antibodies were used at 10 us/ml and IL-2 at 10 U/ml. 
The medium was RPM1 containing 7% FCS and glutamine. Assays 
were run for 72 hr using 96well round-bottomed plates after which 
tritiated thymidine diluted 1:lOO in RPM1 was added to each well, and 
plates were incubated for an additional 16 hr. Thymidine incorporation 
was determined after harvesting cells from each well as described 
(Kasaian and Biron, 1990; Kasaian et al., 1991). 
Recovery of Pancreatic Lymphocytes 
Lymphocytes were isolated from pancreata as described (Oldstone et 
al., 1991; von Herrath et al., 1995). In brief, tissues obtained from 
transgenic mice were freed from fat and surrounding lymphoid tissue. 
After collagenase digestion, lymphoid cells were purified through a 
Ficoll-Hypaque gradient. 
Analysis of IDDM 
IDDM was defined as hyperglycemia, low levels of pancreatic insulin, 
and mononuclear infiltration into the islets. Blood samples were ob- 
tained from the retro-orbital plexus of each mouse at weekly, biweekly, 
or monthly intervals. Amount of glucose in the blood was determined 
using Accucheck II strips (Boehringer-Mannheim, Indianapolis, Indi- 
ana). Mice with glucose values >300 mg/dl were considered diabetic 
(normal blood glucose for age- and sex-matched controls was mean 
f 1 SEM 120-40 mice/group] 165 f 7mgldl). Normal levels of insulin 
were 50 Kg insulinlmg of pancreas * 12 (Oldstone et al., 1991) and 
levels of 20 ug/mg of insulin or less of pancreatic tissue as determined 
by radioimmune assay (Oldstone et al., 1991) were considered abnor- 
mal. Absence or presence of mononuclear cells in the islets was deter- 
mined in tissues fixed in 10% zinc formalin, mounted in paraffin, and 
stained with hematoxylin and eosin (Oldstone et al., 1991; von Herrath 
et al., 1994a). 
Immunohlstochemical Analyses of Tlasues 
lmmunochemical studies were carried out on 6 pm cryomicrotome 
sections. Sections were obtained from tissues quick frozen in CCT 
compound, fixed for 5 min in 1% paraformaldehyde, washed in phos- 
phate-buffered saline (PBS), and incubated with avidin-biotin to block 
nonspecific binding. Primary antibodies consisting of rat anti-mouse 
CD4 (clone RM 4-5). anti-CD6 (clone 536.7). anti-B220 (clone RA3 
682) anti-F4160 (clone A3-1). anti-MAC-l (clone M I/70), anti-class I 
(clone M l/42), anti-class II (clone M5/114). anti-87-2 (clone GL-I), 
anti-IL-2 (clone S4B6), anti-IL-4 (clone BVD6-24G2). anti-IFNT (clone 
XMG1.2) (Pharmingen, San Diego, California; Boehringer Mannheim, 
Indianapolis, Indiana)were applied for 1 hr. After washing, the second- 
ary antibody, biotinylated goat anti-rat immunoglobulin G (IgG) (Vector 
Laboratories, Burlingham, California), was added and the color reac- 
tion obtained after sequential treatment with an avidin-horseradish 
peroxidase conjugate (Boehringer-Mannheim, Indianapolis, Indiana) 
and diaminobenzidine-hydrogen peroxide (von Herrath et al., 1994a). 
Anitbodies for cytokine staining were described earlier by Abbas and 
his colleagues (Bogen et al., 1993). 
Phenotyping and Selective Depletion of Lymphocytes 
Cultured lymphocytes were phenotyped by FACS analysis utilizing 
monoclonal antibodies to murine CD4 (rat monoclonal antibody YTS 
191 .l .l) and CD6 (rat monoclonal antibody MS 169.4.2) (Oldstone 
et al., 1991). For depletion of CD4’ or CDS’ T lymphocyte subsets, 
monoclonal rat anti-mouse antibodies 536-72 and GK 1.5 were used, 
respectively (von Herrath et al., 1994a). In brief, mice were injected 
intravenously with 1 mg10.2 ml of the appropriate antibody 2 days 
before and 4 days after LCMV infection. Depletion was confirmed by 
FACS analysis 7 days after LCMV infection, 
Assessment of Cytoklne Productlon by Slngle Cells 
Cytokines (IL4, IL-lo, IL-2, and IFNT) produced by lymphocytes in- 
filtrating the pancreas or by splenocytes were detected using the 
ELISPOT (Pharmingen, San Diego, California) assay. In brief, 96-well 
Millititer HA plates (Millipore, Bedford, Massachusetts) were coated 
with the respective capture antibodies for IL-2, 114, IL-lo, and IFNT 
diluted 1:206. After overnight incubation at 4OC, plates were washed 
four times with PBS and preincubated with RPM1 containing 10% FCS 
for 1 hr at 37OC. Suspensions of lymphocytes recovered from pan- 
creata or spleens were added at various dilutions in RPMI, 10% FCS 
ranging from 1 x lo’-1 x 102 cells per well, and plates incubated 
overnight at 37OC in a humidified incubator at 5% CO*. The next day, 
plates were washed three times with PBS and three times with PBS 
containing 0.05% Tween 20, then the respective detection antibodies 
for the cytokines were added at 1200 in PBSffween containing 1% 
FCS. Plates were incubated at 4OC overnight and washed three times 
in PBS/Tween before avidin-peroxidase conjugate (Boehringer, India- 
napolis, Indiana) was added at 1:500 dilution. After a 2 hr incubation 
at room temperature, plates were washed three times in PBS and the 
color substrate solution containing 3-amino-9ethylcarbazole and H2C2 
was added and left on the plates for 30 min. Plates were then rinsed 
in water and dried, and spots representing cytokine producing cells 
were counted using an Olympus SZH stereo-zoom microscope. 
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lated by centrif.ugation (500 x g) at 24°Cover30%/70% discontinuous 
Percoll (Pharmacfa) gradients. Cells collected from the 30%/70% inter- 
face were washed and resuspended in 2.462 supernatant. 
Flow Cytometry 
Fluorescein isothiocyanate (FITQconjugated MAbs to CD3 (T cells) 
and 8220 (B cells) were purchased from Pharmingen (La Jolla, Califor- 
nia). FITC-anti-F4/60 (macrophage/microglial cells) was purchased 
from Caltag(South San Francisco, California). Purified anti-B7-1 (clone 
16-1OAl) and anti-B7-2 (GL-1) MAbs were biotinylated using NHS- 
LC-biotin (Pierce, Rockford, Illinois). Avidin-R-phycoerythrin (A-PE) 
was purchased from Molecular Probes (Eugene, Oregon). Cells (2.5- 
II x IO’ CNS mononuclear cells or lOa splenocytes) were incubated 
with a predetermined optimal concentration of biotinylated anti-B7 
MAb in 2.402 supernatant for 30 min at 4OC. Cells were washed in 
isotonic-buffered saline (Baxter; containing 0.1% NaN3 and 1.0% nor- 
mal goat serum) followed by incubation with A-PE and the appropriate 
FITC-conjugated MAb (antiCD3, anti-8220, or anti-F4/60) for 30 min 
at 4°C in thedark. Cellswere washedand resuspended in 1 ml isotonic- 
buffered saline containing 0.1 uglml propidium iodide. Data collection 
and analysis were performed on a FACScan flow cytometer (Becton- 
Dickinson, MountainView, California). Sufficienteventswerecollected 
to assure that at least 4 x 103 large mononuclear cells were analyzed 
per sample. Nonspecific staining was determined by incubating sam- 
ples with the appropriately conjugated isotype-matched control MAbs. 
MLR Assay 
SJUJ splenocytes (4 x 105) isolated from SJUJ mice at different 
stages of disease were irradiated (2006 rads) and incubated with 106 
pg/ml of blocking or control antibodies for 15 min prior to the addition 
of 2 x lo5 purified C57BU6 T cells. Cultures were incubated at 37OC 
for 4 days and pulsed with 1 uCi/well of PH]thymidine for the final 16 
hr. Proliferation is presented as the mean cpm of triplicate wells. SEMs 
were <IO%. 
Ag-Specific DTH 
DTH responses were quantitated using a 24 hr ear swelling assay 
(f&Rae et al., 1992). Prechallenge ear thickness was determined us- 
ing a Mitutoyo model 7326 engineers micrometer (Schlesinger’s Tools, 
Brooklyn, New York). Immediately thereafter, DTH responses were 
elicited by injecting 5 pg of peptide (in 10 cl of saline) into the dorsal 
surface of the ear using a 106 cl Hamilton syringe fitted with a 30 
gauge needle. The increase in ear thickness over prechallenge mea- 
surements was determined 24 hr after ear challenge. Results are ex- 
pressed in units of 10’ inches f SEM. Ear swelling responses were 
the result of mononuclear cell infiltration and showed typical DTH kinet- 
ics (i.e., minimal swelling at 4 hr, maximal swelling at 24-46 hr). 
Statistical Analyses 
Comparison of the percentage of animals showing clinical relapses 
between any two groups of mice were analyzed by x2 using Fisher’s 
exact probability. Comparisons of the mean day of onset of relapse, 
mean peak disease severity, and DTH responses between any two 
groups of mice were analyzed by the Student’s t test. p values < 0.05 
were considered significant. 
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